Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis
Authors:
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 20, 144-152
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosisBrain, 2017
- MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcomeJournal of Neuroinflammation, 2016
- MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and originJournal of Neuroinflammation, 2016
- A clinical approach to diagnosis of autoimmune encephalitisThe Lancet Neurology, 2016
- Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibodyMultiple Sclerosis Journal, 2014
- Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeletonNeurology Neuroimmunology & Neuroinflammation, 2014
- NMDA receptor antibodies associated with distinct white matter syndromesNeurology Neuroimmunology & Neuroinflammation, 2014
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitisThe Lancet Neurology, 2011
- Neuromyelitis optica (NMO) - an autoimmune disease of the central nervous system (CNS)Acta Neurologica Scandinavica, 2010
- A Case of Anti-aquaporin-4 and Anti-glutamate Receptor Antibodies Positive Myelitis Presented with Modest Clinical SignsMagnetic Resonance in Medical Sciences, 2008